Bioactive Products News
-
CD Formulation Unveils Hydrogel Microneedle Patch Technology to Increase Drug Loading Capacity
CD Formulation, a leading pharmaceutical contract service company, has recently unveiled groundbreaking hydrogel microneedle patch technology aiming at increase the drug loading capacity and enhance drug delivery efficiency. The new technology represents a significant advancement in the field of transdermal drug delivery. The hydrogel microneedle patch consists of a patch with tiny microneedles ...
-
Creative Enzymes Unveils a Diverse Range of Premium Extracts for Various Applications
Creative Enzymes, a prominent player in the biotechnology sector, proudly introduces an innovative line-up of exceptional extracts, tailored to meet a wide spectrum of application needs. From plant extracts and animal extracts to mushroom extracts and vegetable powders, etc., this new collection promises to redefine the utilization of natural ingredients across industries. In a dynamic world ...
-
Alfa Chemistry Offers Varieties of Marine Biomaterials for Use in Biomedicine, Cosmetics and Nutraceuticals
The US-located chemical supplier Alfa Chemistry has recently unveiled its wide range of marine biomaterials, opening new possibilities in the fields of biomedicine, cosmetics, and nutraceuticals. With an extensive collection of marine polysaccharides, oligosaccharides, bioactive peptides, marine oils, and microalgae powders, researchers and industries alike can explore the potential of marine ...
-
CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles
Microsphere formulation has been highlighted as a promising dosage form in clinical practice due to its ability to significantly improve patient convenience and compliance. As a trustworthy partner in the field of pharmaceutical formulation, CD Formulation has newly introduced a range of raw materials for the production of microspheres and microneedles, which are highly expected to advance ...
-
CD Genomics Introduces Advanced Exosomal RNA Sequencing Service for Enhanced Molecular Insights
CD Genomics, a leading provider of transcriptomics sequencing solutions, is pleased to announce the launch of its Exosomal RNA Sequencing service. This innovative service is set to provide researchers with comprehensive and accurate analysis of exosomal RNA, facilitating a deeper understanding of their functional significance in various biological processes. Exosomes, small extracellular ...
By CD Genomics
-
Alfa Chemistry Unveils Its Latest Offering of Bioactive Molecules for Scientific Breakthroughs
The US-based chemical supplier Alfa Chemistry recently announced the availability of a range of bioactive molecules for scientific research, including activators, agonists, antagonists, and inhibitors. Bioactive molecules are compounds that can interact with biological systems, such as proteins, enzymes, and the human body, and produce a physiological response. They play a crucial role in the ...
-
CD Formulation Releases Nanoparticle Development Services for Drug Delivery System Research
With the boom of nanotechnology, a growing number of nanomaterials have been applied to the pharmaceutical industry. For instance, nanoparticle-based drug delivery has become research of interest. More recently, CD Formulation, a trust worthy CRO partner for pharmaceutical companies worldwide, announced its commitment to developing suitable drug carriers by incorporating the power of ...
-
Alfa Chemistry Announces the Launch of Extracted Peptides
Demonstrating competence in peptide R&D, production, and sales integration, the US-based chemical supplier Alfa Chemistry recently announced the launch of its peptide product line for researchers across the globe. After this move, a wide range of high-quality extracted peptides, including hydrolyzed protein peptides, fish collagen peptides, marine fish oligopeptides, oyster peptides, sea ...
-
Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives
Kallyope, a leading biotechnology company focused on identifying and developing therapeutics targeting the gut-brain axis, and Brightseed, creators of Forager®, a pioneering artificial intelligence platform that illuminates the connections between nature and human health, have entered a strategic research collaboration to screen plant compounds to identify and validate active agents that can ...
-
Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library
New York, United States—April 21, 2022—Total peptide library construction is a powerful technology for new drug research and development at current. As a pioneering peptide company, Creative Peptides developed a total peptide library based on its proprietary peptide design platform, which allows researchers to develop peptide drugs most efficiently. Total peptide library refers to a collection of ...
-
Synergy Biomedical Launches BIOSPHERE® Flex SP Extremities, Synthetic Bioactive Bone Graft.
Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. Using Synergy’s proprietary BIOSPHERE® Technology, BIOSPHERE® FLEX SP Extremities is a sheet putty composed of innovative spherical bioactive glass granules combined with a porous collagen/sodium hyaluronate ...
-
Synergy Biomedical Announces Publication of Core Scientific Study on Its BioSphere® Bone Graft Technology
Synergy Biomedical, LLC, a developer of innovative bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. This study was conducted by Synergy’s founder, Mark Borden Ph.D. and a team of clinical and basic science collaborators, and ...
-
Peptide Discovery Platform And Expand Globally
Nuritas, a biotechnology company revolutionizing the discovery and development of plant-based bioactive peptides, has closed a $45 million USD Series B funding round. The investment, led by Chicago-based Cleveland Avenue, LLC, includes Grosvenor’s Wheatsheaf Group, the European Circular Bioeconomy Fund (ECBF), Singapore-based Vertex Holdings, Nutresa Ventures/ Veronorte and CJ. Cultivian ...
By Nuritas Ltd.
-
Matexcel Enables Nano-bio Services with Various Technologies
Matexcel, a leading service provider in material science, with years of commitment to supplying quality nanoparticles, metal powders, natural material, graphene, and other materials for customers worldwide from both academic and industry, now offers a comprehensive list of nano-bio services to help with scientists’ research. The post-gene era provides a good opportunity for the ...
By Matexcel
-
Defymed at the conference of the European Society for Biomaterials
September 5th-9th: Defymed at the conference of the European Society for Biomaterials Last year Defymed attended for the first time to the World Biomaterials Congress which held on December 11-15, 2020 via an excellent virtual platform. This year Defymed confirms its strong interest on biomaterials, improvement performed to process them and how they could be used in conjunction with other ...
By Defymed
-
Sumitomo Chemical and Nuritas Announce Partnership on the Discovery of Bioactive Peptides Through Artificial Intelligence
Sumitomo Chemical Co., Ltd. and Nuritas announced today that they have signed a multi-year partnership to sustainably support the food production systems needed to feed the growing global population. This hugely important partnership will see Nuritas deploy its award-winning and novel technology platform, which uses Artificial Intelligence and DNA analysis to predict, unlock, and validate highly ...
By Nuritas Ltd.
-
TISSIUM Awarded 2.2M€ from i-Nov Competition to Address Chronic Rhinosinusitis
TISSIUM, a privately-owned life science company developing fullysynthetic, biomorphic programmable polymers, announced today it has been awarded 2.2M€ in financing that will accelerate its development of a drug-eluting tissue adhesive to address the unmet needs of Chronic Rhinosinusitis (CRS) patients. The funding comes from the Investments for the Future program (Programme ...
By TISSIUM
-
Synergy Biomedical Announces FDA Clearance of BIOSPHERE FLEX
Synergy Biomedical, LLC, a developer of innovative biomaterial products, announced today that it has received FDA 510(k) clearance of BIOSPHERE® FLEX and is targeting a launch in the 4th quarter of 2018. Based on Synergy’s BioSphere® Technology, BIOSPHERE® FLEX is composed of porous, bioactive glass granules combined with a porous collagen and sodium hyaluronate scaffold. The ...
-
CSIRO and Clover to develop new, healthy ingredients for infant formulas
CSIRO and ingredients manufacturer, Clover Corporation Limited, are developing the next generation of nutritional ingredients for infant formulas. CSIRO and leading Australian ingredients manufacturer, Clover Corporation Limited, have agreed to work together on the development of the next generation of nutritional ingredients for infant formulas. “While natural breast milk is the gold ...
-
New Advisory Board will guide development of CrossFire Beilstein Database
Eminent panel to steer continuing enhancement of essential chemistry and pharma research resource Frankfurt, Germany – Elsevier Information Systems GmbH, a subsidiary of Elsevier, the leading global publisher of scientific, technical and medical information, is pleased to announce the establishment of an Advisory Board with a mandate to provide recommendations on the scope, coverage, quality ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you